Carter Jason S 4
4 · Vera Therapeutics, Inc. · Filed Nov 20, 2024
Insider Transaction Report
Form 4
Carter Jason S
Chief Legal Officer
Transactions
- Award
Class A Common Stock
2024-11-18+53,000→ 53,000 total - Award
Stock Option (right to buy)
2024-11-18+108,000→ 108,000 totalExercise: $44.81Exp: 2034-11-17→ Class A Common Stock (108,000 underlying)
Footnotes (2)
- [F1]Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") under the Issuer's 2024 Inducement Plan. One-fourth of the RSUs vest on each February 20, May 20, August 20 and November 20 following the vesting commencement date of November 18, 2024, subject to the Reporting Person's continuous service through each vesting date.
- [F2]1/4 of the shares subject to the option vest on November 18, 2025, and 1/48 of the shares vest monthly thereafter, subject to continuous service of the Reporting Person through each vesting date.